Accuracy of Elastography for Differentiation Benign and Malignant Breast Lesions

Abstract

Introduction: Elastography is considered a non-invasive imaging methodology which decides the tumors concurring to their solidness. To survey the extra symptomatic esteem of elastography in combination with B-mode ultrasound in the characterization of solid breast lesions.Purpose: To assess the role of elastography in characterizing breast masses and utilize of elastography to ultrasound for separate benign and malignant breast lesions. Methods:The consider was conducted on 80 participants, each participant was subjected to complete history taking, exhaustive clinical examination. Females with a single undiagnosed solid breast lesion between March and May 2018. All patients had routine US and elastography utilizing GE Voluson E6 5-17 MHz linear probe.Results: Among the 80 patients included in this study. 31 breast lesions were malignant & 49 were benign. B-mode ultrasound was performed, and the lesions were categorized agreeing to the (BI-RADS) where chi-square statistical test uncovered that BI-RADS categories were essentially expanded among malignant cases (P < 0.001). While the elastography classified concurring to altered Ueno and Ito elasticity score framework which benign lesions had elastography score 1, 2, 3 and 4 whereas malignant breast lesions had elastography score 4 and 5. Conclusion:Elastography is a non-invasive imaging procedure which is done in the same session of ultrasound in an endeavor to extend and progress the precision of diagnostic effectiveness of ultrasound.

Characterization of lesions of the Breast by using diagnostic imagining Technique: Ultrasound Elastography

“…Although both mammography and ultrasonography have a high sensitivity but both diagnostic tools have considerable drawbacks. 4 in thick breasts, mammography can produce false negative findings, while ultrasound's specificity in solid breast lesions is weak. 5 BIRADS criteria provide a large number of false positive outcomes, increasing the number of biopsies with a cancer detection rate of just 10%-30%.…”